I-Cell Disease (Mucolipidosis Type II) Follow-up
- Author: Karl S Roth, MD; Chief Editor: Bruce Buehler, MD more...
Complications
- Respiratory infections, such as pneumonia and otitis media, frequently recur in patients with I-cell disease.
- Depending on the extent of neurologic compromise, aspiration pneumonia can also become a recurrent problem.
- Congestive heart failure results from chronic valvular insufficiency.
- Atlantoaxial instability can develop because of abnormally shaped cervical vertebrae. If this occurs, patients should be monitored and, eventually, surgically stabilized to avoid the risk of spinal cord injury.
Prognosis
- Psychomotor retardation is progressive, and patients with cardiopulmonary complications usually die by age 10 years.
Patient Education
- Families must be educated about the genetic basis of this disorder, including recurrence risks, identification of carriers, and the availability of prenatal diagnosis for future at-risk pregnancies.
Dierks T, Schlotawa L, Frese MA, Radhakrishnan K, von Figura K, Schmidt B. Molecular basis of multiple sulfatase deficiency, mucolipidosis II/III and Niemann-Pick C1 disease - Lysosomal storage disorders caused by defects of non-lysosomal proteins. Biochim Biophys Acta. Apr 2009;1793(4):710-25. [Medline].
Leroy JG, DeMars RI, Opitz JM. I-cell disease. Birth Defects Orig Artic Ser. 1969;4:174-85.
Spranger JW, Wiedemann HR. The genetic mucolipidoses. Diagnosis and differential diagnosis. Humangenetik. 1970;9(2):113-39. [Medline].
Poorthuis BJ, Wevers RA, Kleijer WJ, et al. The frequency of lysosomal storage diseases in The Netherlands. Hum Genet. Jul-Aug 1999;105(1-2):151-6. [Medline].
Otomo T, Higaki K, Nanba E, Ozono K, Sakai N. Lysosomal storage causes cellular dysfunction in mucolipidosis II skin fibroblasts. J Biol Chem. Oct 7 2011;286(40):35283-90. [Medline]. [Full Text].
Coutinho MF, Santos LD, Girisha KM, Satyamoorthy K, Lacerda L, Prata MJ, et al. Mucolipidosis type II a/ß with a homozygous missense mutation in the GNPTAB gene. Am J Med Genet A. Apr 11 2012;[Medline].
Krivan G, Timar L, Goda V, et al. Bone marrow transplantation in non-malignant disorders. Bone Marrow Transplant. Dec 1998;22 Suppl 4:S80-3. [Medline].
Bocca G, Monnens LA. Defective proximal tubular function in a patient with I-cell disease. Pediatr Nephrol. Aug 2003;18(8):830-2. [Medline].
Breningstall GN, Tubman DE. Magnetic resonance imaging in a patient with I-cell disease. Clin Neurol Neurosurg. May 1994;96(2):161-3. [Medline].
Goodman ML, Pang D. Spinal cord injury in I-cell disease. Pediatr Neurosci. 1988;14(6):315-8. [Medline].
Gopaul KP, Crook MA. The inborn errors of sialic acid metabolism and their laboratory investigation. Clin Lab. 2006;52(3-4):155-69. [Medline].
Kawashima I, Ohsawa M, Fukushige et al. Cytochemical analysis of storage materials in cultured skin fibroblasts from patients with I-cell disease. Clin Chim Acta. Mar 2007;378(1-2):142-6. [Medline].
Kornfeld S, Sly WS. I-cell disease and pseudo-Hurler polydystrophy: disorders of lysosomal enzyme phosphorylation and localization. Metab Mol Bases Inherited Dis. 2001;3:3469-82.
Kudo M, Brem MS, Canfield WM. Mucolipidosis II (I-cell disease) and mucolipidosis IIIA (classical pseudo-hurler polydystrophy) are caused by mutations in the GlcNAc-phosphotransferase alpha / beta -subunits precursor gene. Am J Hum Genet. Mar 2006;78(3):451-63. [Medline].
Leroy JG, Martin JJ. Mucolipidosis II (I-cell disease): present status of knowledge. Birth Defects Orig Artic Ser. 1975;DA - 19760301(6):283-93. [Medline].
Leroy JG, Spranger JW, Feingold M, Opitz JM, Crocker AC. I-cell disease: a clinical picture. J Pediatr. Sep 1971;79(3):360-5. [Medline].
Tiede S, Storch S, Lubke T, et al. Mucolipidosis II is caused by mutations in GNPTA encoding the alpha/beta GlcNAc-1-phosphotransferase. Nat Med. Oct 2005;11(10):1109-12. [Medline].

